SCHEMBL8307577

SCHEMBL8307577

Cc1nsc(Cl)c1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPK1 P28482 1/20 0.38
DAO P14920 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
KMT2A Q03164 2/20 0.34
CSNK2A1 P68400 1/20 0.34
PIM3 Q86V86 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
MEN1 O00255 1/20 0.34
KDM4E B2RXH2 5/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
PKM P14618 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
POLB P06746 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8306201 0.79 L3MBTL1 (0.42) ALDH1A1HPGDTSHRSMN1; SMN2L3MBTL1
SCHEMBL6261011 0.77 L3MBTL1 (0.36) ALDH1A1HPGDSMN1; SMN2L3MBTL1MAPK1
Hydrochloric Acid SCHEMBL8761311 0.76 L3MBTL1 (0.35) ALDH1A1HPGDSMN1; SMN2L3MBTL1MAPK1
SCHEMBL3381063 0.75 PDE4D (0.51) ALDH1A1HPGDSMN1; SMN2MAPK1KMT2A
SCHEMBL9956341 0.74 L3MBTL1 (0.38) ALDH1A1HPGDTSHRSMN1; SMN2L3MBTL1
SCHEMBL29790182 0.74 L3MBTL1 (0.38) ALDH1A1HPGDTSHRSMN1; SMN2L3MBTL1
SCHEMBL8188239 0.74 KDM4E (0.40) ALDH1A1HPGDTSHRSMN1; SMN2L3MBTL1
SCHEMBL3567804 0.71 ALDH1A1 (0.38) ALDH1A1L3MBTL1CSNK2A1PIM3CLK4
SCHEMBL14710261 0.71 L3MBTL1 (0.36) ALDH1A1L3MBTL1HCAR2KMT2ACSNK2A1
SCHEMBL3574484 0.71 L3MBTL1 (0.46) ALDH1A1L3MBTL1KMT2ACSNK2A1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors SIGNALRX PHARMACEUTICALS, INC. (US) 2023-09-19 US disclosed
CN-1058490-C Tetrazolinone derivatives BAYER AGROCHEM KK (JP) 2000-11-15 CN disclosed
EP-0695748-B1 Tetrazolinone herbicides BAYER AGROCHEM KK (JP) 1999-05-06 EP disclosed
US-5589439-A HERBICIDES NIHON BAYER AGROCHEM K.K. (JP) 1996-12-31 US disclosed
EP-0695748-A1 Tetrazolinone herbicides NIHON BAYER AGROCHEM K.K. (JP) 1996-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors CDK1, CDKN1A, CDKL1 ALDH1A1 3077/4885HPGD 2967/4885TSHR 2452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.